Belarus vs Côte d'Ivoire: Previously treated cases tested for RR-/MDR-TB
Belarus
100.0%
in 2024
Côte d'Ivoire
100.0%
in 2024
Belarus rank
1st
Côte d'Ivoire rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Belarus
- Côte d'Ivoire
How they compare
Belarus currently reports 100.0% against 100.0% in Côte d'Ivoire, a difference of 0.0%.
The two have swapped places 3 times across 16 shared years of data; in 2008 it was Belarus ahead.
Belarus ranks 1st and Côte d'Ivoire ranks 1st of 180 countries.
Belarus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belarus | Côte d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 12.8% | 87.2% | Belarus |
| 2010s | 91.6% | 60.3% | 31.3% | Belarus |
| 2020s | 100.0% | 98.4% | 1.6% | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Belarus or Côte d'Ivoire?
- Belarus, at 100.0% against 100.0% in Côte d'Ivoire as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Belarus and Côte d'Ivoire?
- 0.0%, with Belarus ahead.
- How many years of comparable data are there for Belarus and Côte d'Ivoire?
- 16 years are reported by both, from 2008 to 2024.
- How do Belarus and Côte d'Ivoire rank globally for previously treated cases tested for rr-/mdr-tb?
- Belarus ranks 1st and Côte d'Ivoire ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.